Abstract
As part of the marketing process of the tetravalent conjugate vaccine Menveo® against invasive meningococcal infections, the French High Council of Public Health (Haut Conseil de la santé publique) issued recommendations after consultation with the Technical Committee on Vaccination (Comité Technique de Vaccination) and the Committee on travel-related illness and disease import.
Source: http://www.hcsp.fr/docspdf/avisrapports/hcspa20100625_vaccmeninMenveo.pdf
Europe
France
health policy
Meningococcal disease
